1H NMR relaxometry and X-ray study of PCL/nevirapine hybrids  by Monteiro, Mariana S.S.B. et al.
e at SciVerse ScienceDirect
Polymer Testing 32 (2013) 553–566Contents lists availablPolymer Testing
journal homepage: www.elsevier .com/locate/polytestMaterial characterisation1H NMR relaxometry and X-ray study of PCL/nevirapine
hybrids
Mariana S.S.B. Monteiro a, Fabián Vaca Chávez b, Pedro. J. Sebastião b,c,
Maria Inês Bruno Tavares a,*
a Instituto de Macromoléculas Professora Eloisa Mano, Universidade Federal do Rio de Janeiro (UFRJ), Centro de Tecnologia, Bloco J,
Cidade Universitária, 21941-598 Ilha do Fundão, CP 68525, Rio de Janeiro, RJ 21945-970, Brazil
bCondensed Matter Physics Centre, University of Lisbon, Lisbon, Portugal
cDepartamento de Física, Instituto Superior Técnico, Technical University of Lisbon, Lisbon, Portugala r t i c l e i n f o
Article history:
Received 12 December 2012
Accepted 26 January 2013
Keywords:
Polycaprolactone
Nevirapine
Nanoparticles
Proton spin-lattice relaxation time
Fast-ﬁeld cycling* Corresponding author. Tel.: þ55 21 25628103; fa
E-mail address: mibt@ima.ufrj.br (M.I.B. Tavares
0142-9418/$ – see front matter  2013 Elsevier Ltd
http://dx.doi.org/10.1016/j.polymertesting.2013.01.01a b s t r a c t
Polycaprolactone (PCL) hybrids containing layered silicates, silica and dioxide titanium
were developed and used as matrixes for the incorporation of nevirapine. These systems
were characterized by X-ray diffraction (XRD) and proton nuclear magnetic resonance
(NMR) relaxometry. The XRD showed that the PCL crystallization is hindered with higher
amounts of nevirapine and that the drug has an amorphous distribution in the PCL matrix.
The NMR showed that the hybrids present three distinct environments: crystallites, rigid-
amorphous and ﬂexible-amorphous regions, with three distinct spin-lattice relaxation
times, T11, T12, T13. The proton relaxometry showed that the PCL chains have more
restricted motions in the presence of Viscogel organoclay S7 comparing to TiO2 and SiO2.
The presence of nevirapine and nanoparticles together decreased the polymer chain
mobility, especially in the amorphous regions. Both T12 and T13 dispersions could be
interpreted in terms of power laws T12, T13w n
p. In the case of T12, the exponent obtained
was around 0.73, which in the frame of the renormalized Rouse model could be associated
with a type I mesophase region, indicating some constraint in the amorphous part.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Nanoscience and nanotechnology have been increas-
ingly used in the development of new products and pro-
cesses, especially those for biomedical applications. Several
studies have reported new nanobiomaterials for modiﬁed
drug release systems, which have many advantages
compared with the isolated polymers or other pharma-
ceutical excipients [1–3]. Polycaprolactone (PCL) is
currently used in controlled drug release systems as well as
in other medical applications. It is linear semi-crystalline
polyester and is biocompatible and biodegradable, eitherx: þ55 21 25628063.
).
. All rights reserved.
6through hydrolytic or enzymatic cleavage of the macro-
molecular chains [4–7].
The blending of polymer materials as PCL with inorganic
nanoparticles, such as montmorillonite clay, silica and tita-
nium dioxide, can provide new compounds. These nano-
structured materials are physically more stable and have
other improved properties for pharmaceutical purposes [8–
10]. Thus, polymer nanostructured materials are interesting
materials for producing modiﬁed release systems [2,11].
In this work, the PCL nanostructured materials devel-
oped were used as matrices for the incorporation of nevi-
rapine. Nevirapine (Nev) is a non-nucleoside reverse
transcriptase inhibitor of human immunodeﬁciency virus
type 1 (HIV-1). It blocks polymerase activity after binding
directly to the HIV-1 reverse transcriptase, leading to the
disruption of the enzyme’s catalytic site [12–14].
Fig. 1. Structure of PCL.
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dynamics of new materials, especially those intended for
application in the pharmaceutical sector. The physical
properties depend on themolecular dynamics and inﬂuence
the ﬁnal formulation, biological activity, manufacturing
process and storage conditions chosen for pharmaceutical
systems [15]. One of the best techniques to measure the
molecular dynamics of pharmaceutical and polymer sys-
tems is proton nuclear magnetic resonance (NMR) relax-
ometry [16].
ProtonNMR relaxometrymeasures the energy exchange
between proton spins of the hydrogen nuclei and the en-
ergy exchange between the proton spin system and the
surrounding lattice. When the proton spin-lattice relaxa-
tion time (T1) is measured over a broad range of Larmor
frequencies (nL ¼ gB/2p, where B is the external magnetic
ﬁeld and g is the 1H gyromagnetic ratio), it is possible to
obtain detailed information regarding the molecular dy-
namics of the system. Spin-lattice relaxation is highly
sensitive, not only to local molecular rotations/reor-
ientations but also to translational self-diffusion of mole-
cules because the 1H spin-lattice relaxation depends on the
dipolar spin interactions that can occur between inter or
intramolecular spins [17–21].
Due to the low signal-to-noise ratio at low Larmor fre-
quencies, conventional T1 measurements are limited to
frequencies above around 4MHz. FFC NMR relaxometry has
been used to extend the T1 measurements below the MHz
range. Both techniques are currently extensively used in the
study of molecular dynamics in polymer melts, polymer
networks and liquid crystalline systems. This technique is a
convenient tool to detect changes in motions at the mo-
lecular level, since it allows the measurement of T1 in the
broad frequency range of 1 kHz–10 MHz, without signal
degradation, since the free-induction decay always us to
detect at a sufﬁciently high magnetic ﬁeld, B, (e.g., nL
>8 MHz) [22–25]. When measured at different Larmor
frequencies, the spin-lattice time can detect molecular
motions, with a broad range of correlation times. At MHZ
Larmor frequencies, T1 is mainly determined by individual
molecular reorientations and by local molecular trans-
lational displacements. Both dynamic processes are usually
classiﬁed as “fast molecular motions”. To get an insight into
the “slow” molecular dynamics in the kilohertz frequency
range, FFC has to be applied [26].
In this paper, we report experiments to characterize
PCL/nanoparticle/nevirapine hybrids using X-ray diffrac-
tion (XRD) and proton nuclear magnetic resonance (NMR)
relaxometry. NMR relaxometry measurements were per-
formed to study the mobility of PCL macromolecules and of
the drug, helping to make inferences about their conﬁne-
ment level inside the hybrids.
2. Experimental
2.1. Materials
Polycaprolactone (PCL) Mn ¼ 80,000, supplied by
Sigma Aldrich, was used as the polymer matrix (Fig. 1).
The organoclay Viscogel S7, containing the dimethyl
benzyl hydrogenated tallow ammonium group as amodiﬁer, was obtained from Bentec-Laviosa Chimica
Mineraria (Italy). This clay is based on montmorillonite,
which is a sodium aluminum hydrosilicate, morphologi-
cally constituted of alumina octahedrons sandwiched be-
tween two layers of silica tetrahedrons. The layer
thickness is around 1 nm and the surface area is around
800 m2/g. Hydrophilic silica oxide particles (SiO2) were
supplied by Evonik (Brazil), named Aerosil A200. They
have a speciﬁc surface area of 170 mg2 g1 and an average
primary particle size of 12 nm. Titanium dioxide particles
(TiO2) were supplied by DuPont (Brazil) and they have a
speciﬁc surface area of 50 mg2 g1 and an average primary
particle size of 25 nm. Nevirapine was supplied by
Oswaldo Cruz Foundation of Rio de Janeiro (Brazil).
Chloroform was purchased from TediaBrazil. All materials
were used without further modiﬁcation.
2.2. Preparation of hybrids
The PCL ﬁlm was produced using a solvent casting
technique. The PCL granules were dissolved in chloroform
at room temperature overnight with vigorous stirring to
obtain a concentration of 5% w/v. The solutionwas put into
a glass Petri dish, which was covered and placed at room
temperature for slow evaporation. The dried ﬁlmwas dried
at vacuum for 48 h. The PCL/clay nanostructured materials
were also prepared through the solvent casting technique,
using CHCl3 as the solvent. The solutions of PCL and
organoclay were added in a ﬂat-bottom insulated
ﬂask. The ﬂasks with the isolated solutions were sealed
and stirred at room temperature for 24 h. After that, the
solutions were mixed and left for 24 h under stirring,
which was poured into Petri dishes and kept at room
temperature. The nanostructured ﬁlms were dried
under vacuum for 48 h and all the samples were stored
in desiccators until use. Films with 3% w/w of Viscogel S7
clay were obtained. The same procedure was performed
for the titanium and silica dioxide particles, but the
ﬁnal concentration of both particles in each system was
0.25% w/w.
The nevirapine was added to the PCL by dissolving it in a
small amount of chloroform and then stirring the solution
for 20–30 min before pouring into a glass Petri dish. The
amounts of nevirapine in each systemwere 5%,10% and 20%
w/w in relation to the PCL.
2.3. Characterization techniques
2.3.1. X-ray diffraction
The crystalline structure of the PCL and PCL/nevirapine
hybrids were investigated by X-ray diffraction using a
Rigaku D/Max 2400 diffractometer, with nickel-ﬁltered
CuKa radiation of wavelength 1.54 A, at room tempera-
ture. The 2q scanning range was varied from 2 to 30, with
Fig. 2. XRD curves of nevirapine, PCL and PCL/nevirapine hybrids.
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crystallinity of the samples was calculated from the inte-
grated area of X-ray diffraction data, using Fytik software.
The areas under the crystalline and amorphous phase were
determined in arbitrary units, and the degree of crystal-
linity (Xc) and amorphous content (Xa) were obtained using
the following relationship (Expression 1) [27]:
Xc ¼ IcIa þ Ic; Xa ¼
Ia
Ia þ Ic (1)
where Ia and Ic are the integrated intensities corresponding
to the crystalline and amorphous phases.
2.3.2. NMR measurements
The proton spin-lattice relaxation timewasmeasured as
a function of the Larmor frequency between 10 kHz and
300 MHz at a temperature of 23 C for all samples and at
37 C for 8 samples (see below).
The measurement of T1 over a broad frequency range
(e.g., 10 kHz–300 MHz) requires the use of both fast-ﬁeld
cycling and classical inversion-recovery experimental
techniques. Due to signal-to-noise limitations, the standard
inversion-recovery technique is usually used for Larmor
frequencies above 4 MHz. Below this frequency, fast-ﬁeld
cycling relaxometry techniques are then used. The pro-
ton’s spin system is subjected to fast changes of the
external magnetic ﬁeld, BP/ BEsBE/ BD, which pro-
duce an evolution of the magnetization in the desired
magnetic ﬁeld (BE), characterized by T1(BE). The spins sys-
tem is always polarized at a ﬁxed magnetic ﬁeld BP and the
resonance free-induction decay (FID) signal is always
detected in a ﬁxed magnetic ﬁeld (BD > BE). The signal-to-
noise limitations associated with the NMR signal detection
for low Larmor frequencies are overcome with this tech-
nique because the FID signal is always acquired at a
reasonably high resonance frequency (8.9 MHz in the
present study) [25,28].
The T1 dispersion was obtained using three different
spectrometers. A home-developed fast-ﬁeld cycling (FFC)
relaxometer operating with polarization and detection
ﬁelds of 0.21 T (nL¼ 8.9MHz) and a switching timeof 2–3ms
was used for measurement at frequencies between 10 kHz
and 9 MHz. A Bruker Avance II console was used together
with a variable-ﬁeld iron-core magnet and a 7 T supercon-
ductor electromagnet to cover the frequencies from 10 to
90 MHz, and 300 MHz, respectively. T1 was measured
applying the inversion recovery (p)x  s  (p/2)x,x –
acquisition sequence in the case of the standard NMR
spectrometers.
2.3.3. Data analysis
1H NMR relaxation times were obtained by analyzing
the recorded magnetization decay data using a home-
developed NMR console using MATLAB 6.5 [24] and a
home-written data processing software system [28].
To analyze the proton relaxation behavior, we intro-
duced a three-exponential relaxation model with the
assumption that these three different relaxation compo-
nents, named T11, T12 and T13, are related to the crystalline,
rigid-amorphous and ﬂexible-amorphous parts, respec-
tively [7].M ¼ aþ bces=T11 þ bð1 c dÞes=T12 þ bdes=T13 (2)
where, a and b are the free components; c is the crystalline
value for each sample and d is the value obtained for each
sample in the 1H NMR analysis at 300 MHz. Therefore, the
weighting factor for each component depends on the cor-
responding number of protons.
3. Results and discussion
3.1. XRD measurements
Polymer ﬁlms are preferred due to their slow degrada-
tion and large surface area. PCL ﬁlms have importance
in controlled drug delivery because their thin layers
are resistant to change of crystallinity and segmental
motions [5].
The XRD technique was used to identify, characterize
and calculate the crystalline value of the hybrids. The XRD
patterns of PCL and PCL hybrids with nevirapine are shown
in Figs. 2–5. There are two distinct peaks observed at
2q ¼ 21.6 and 2q ¼ 23.8 (Figs. 2–5), which are indexed to
the (110) and (200) planes, respectively, of an orthorhombic
crystalline structure of PCL [29,30]. The XRD trace of ne-
virapine displays a characteristic peak at 2q¼ 9.5, which is
associated with the anhydrous form [13].
As can be seen in Fig. 2, the samples containing 5 and
10% w/w of nevirapine presented the same peaks at
2q ¼ 21.4 and 23.8, suggesting that the crystallization of
PCL was not affected by the addition of nevirapine. How-
ever, the largest amount of nevirapine affected the in-
tensity of the PCL peaks. Beyond that, the disappearance of
nevirapine crystal peaks indicates an amorphous distribu-
tion of the drug inside the PCL matrix [31].
According to Fig. 3, the XRD pattern for the Viscogel S7
organoclay has a reﬂection at about 2q ¼ 5.14, corre-
sponding to a basal spacing of 17.19 A, and an almost
imperceptible reﬂection for the PCL/Viscogel S7 nano-
structured materials, demonstrating disordering in this
clay’s layers. However, the increase in the peaks’ intensity
did not indicate a strong interaction between the two
nanostructured material components. Therefore, an inter-
calated nanostructured material was probably achieved
[19,32]. As the nevirapine concentration increased, there
Fig. 3. XRD curves of nevirapine, Viscogel S7 clay, PCL/S7 clay and PCL/S7/
nevirapine hybrids.
Fig. 5. XRD curves of nevirapine, TiO2 nanoparticles, PCL/TiO2 and PCL/TiO2/
nevirapine hybrids.
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gesting that PCL crystallization was affected by the higher
amount of nevirapine.
Fig. 4 shows the XRD curves of the PCL/Aerosil A200
hybrid materials. The X-ray diffraction showed that silica
oxide nanoparticles are predominantly amorphous [33].
The strong and sharp crystalline peaks attributed to the
crystallographic planes of the PCL crystal remained after
the SiO2 incorporation. Consequently, the crystallization of
PCL did not change in the hybrid materials. The PCL/SiO2/
nevirapine at 5% w/w presented better dispersion of the
drug than the hybrids with 20% w/w of nevirapine, a fact
can be seen through the decrease in the intensity of the PCL
crystalline peaks. Thus, the incorporation of a higher
amount of nevirapine, 20% w/w, inﬂuenced the PCL crys-
tallization, and hence the drug distribution in this system.
Fig. 5 shows the XRD curves of the PCL/TiO2 hybrid
materials. The introduction of a small amount of TiO2
modiﬁed the PCL crystallinity, as can be seen from the
decrease of the PCL crystalline peaks. Therefore, the addi-
tion of nevirapine at 5 and 10% w/w caused some modiﬁ-
cations in the crystallization process, offsetting the TiO2
introduction and showing that nevirapine did not have a
strong interactionwith the PCL/TiO2 hybrid. That result can
be veriﬁed by the increase of the PCL crystalline peaks.
The addition of 20% w/w nevirapine modiﬁed the PCLFig. 4. XRD curves of nevirapine, SiO2 nanoparticles, PCL/SiO2 and PCL/SiO2/
nevirapine hybrids.crystallization and probably the drug dispersion in this
hybrid, since it is not possible to see the characteristic PCL
peaks.
In all the systems, the PCL crystallinity decreased when
the amount of nevirapine increased, suggesting that the
encapsulation of nevirapine can lead to some changes in
the semi-crystalline PCL structure, leading to a less ordered
compound [6,31]. A possible explanation is the hydrogen
bond and the electrostatic interaction between PCL and
nevirapine.
The crystallinity of all the hybrids was obtained by curve
ﬁtting to calculate the area of each peak. Linear background
correction was applied separately to the observed peaks
before obtaining the area of each peak, for which we
assumed a Gaussian proﬁle. The calculated crystallinity is
shown in Table 1.
3.2. NMR relaxometry
Fig. 6 presents the spin-lattice relaxation dispersion in
the Larmor frequency range, between 10 kHz and 300MHz,
for the PCL sample. The magnetization decay behavior for
PCL is well described by a triexponential behavior, charac-
terized by three spin-lattice relaxation times, in the fre-
quency range from around 300 kHz to 300 MHz. ThisTable 1
Crystalline values for PCL and PCL hybrids.
Samples Xc (%)
PCL 53
PCL/5% Nev w/w 48
PCL/10% Nev w/w 40
PCL/20% Nev w/w 42
PCL/S7 39
PCL/S7/5% Nev w/w 38
PCL/S7/10% Nev w/w 36
PCL/S7/20% Nev w/w 44
PCL/SiO2 44
PCL/SiO2/5% Nev w/w 46
PCL/SiO2/10% Nev w/w 50
PCL/SiO2/20% Nev w/w 47
PCL/TiO2 42
PCL/TiO2/5% Nev w/w 40
PCL/TiO2/10% Nev w/w 35
PCL/TiO2/20% Nev w/w 38
Fig. 6. Frequency dependence of the proton spin-lattice relaxation time T1
for PCL.
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lattice relaxation between three proton subsystems. How-
ever, the magnetization decay, for frequencies below
150 kHz, is described by monoexponential behavior, char-
acterized by a single T1.
Since the proton spin-lattice relaxation time depends on
the dipolar interactions between the intra- or inter-
molecular hydrogen proton spins modulated by molecular
motions, it provides information about the molecular
mobility of polymer chains. Consequently, this technique
can be used to study phase composition based on the
heterogeneities of molecular mobility in polymer chains
[25,34,35].
In view of the obtained T1 decomposition in three
distinct components, a possible schematic representation
of the PCL structure is proposed in Fig. 7 [7,36–38]:
(i) Rigid crystallites: This is the most organized region, so
the proton motions are slower and restricted, pre-
senting higher T1 (T11).Fig. 7. Schematic representation of PCL.(ii) Rigid-amorphous regions: The PCL chains in this re-
gion have intermediate mobility, presenting interme-
diate T1 values (T12). This region likely has polymer
chains stuck in the crystalline parts.
(iii) Flexible-amorphous regions: The PCL chains are free,
showing faster protons motions, with more mobility
and shorter intrinsic T1 (T13).
PCL (see Fig. 1) crystallizes into layers in a planar zigzag
conformation within an orthorhombic unit cell, as seen in
the XRD analysis (see Fig. 2). The ester groups are slightly
twisted from the plane of the zigzags. Solid-state NMR in-
vestigations by Kaji and Horii showed that the conforma-
tion of the crystalline CH2 sequences ﬂuctuate quickly
while the carbonyl groups remain virtually rigid [39].
However, the CH2 sequence in the amorphous part has
more freedom, enabling it to undergo some twisting and to
propagate this effect through the polymer chain [40,41].
The proton spin-lattice relaxation time dispersion pro-
ﬁles were obtained for PCL hybrids and shown in Fig. 8,
which shows the spin-lattice relaxation dispersion in the
Larmor frequency range between 10 kHz and 300 MHz. The
magnetization decays observed for all the PCL hybrids were
also described by three exponential components, charac-
terized by three spin-lattice relaxation times. Although this
magnetization decay is observed for PCL/S7, PCL/SiO2 and
PCL/TiO2 in the frequencies up 400 kHz, 1 MHz and
600 KHz, respectively, below these frequencies there is only
one T1, since the other two relaxation times were too short
to be measured with our experimental FFC relaxometer. All
the samples showed a clear T1 frequency dependence in the
full range of frequencies considered.
It is interesting to note that the dispersion of T11 is quite
similar in the frequency range between 10 kHz and
300 MHz for all hybrids, although a small increase in T11 is
observed for the PCL/S7 sample. This suggests that the PCL
chains have more restricted motions in the presence of S7
clay, indicating that the clay disturbs the crystalline regions
of the PCL [9,10]. The observed increase of the T11 value forFig. 8. Comparison of the frequency dependence of the proton spin-lattice
relaxation time for the PCL hybrids.
M.S.S.B. Monteiro et al. / Polymer Testing 32 (2013) 553–566558PCL/S7 suggests that this system is more ordered. However,
the XRD analysis showed a decrease in the crystalline value
in comparison to the neat PCL. A possible explanation for
these apparently contradictory observations might be
related to a decrease in the PCL crystal size or a decrease in
the number of crystals. The T12 of PCL/S7 hybrid is higher
than that of the PCL, which can be attributed to a decrease
in the PCL chain motions in the amorphous part, suggesting
also that the rigid-amorphous regions are more ordered in
the presence of the S7 clay [42].
The incorporation of nanoparticles of TiO2 and SiO2
seems to have less inﬂuence on the polymeric dynamics,
since there was only a small increase in the T11 and T12
values, indicating that the chains’ motions are also slower
and more restricted in this system. Nevertheless, the
dispersion of T12 for the PCL/TiO2 (Fig. 8) in the frequency
range between 100 kHz and 400 kHz shows a distinct
proﬁle in comparison to the other hybrids. Thus, the
introduction of TiO2 in the PCL matrix affects the slower
PCL chain modes, since the T1 values in the megahertz
range in polymers is related to relaxation by fast motions,
such as segment ﬂuctuation or rotations of larger side
groups, while the T1 in the kilohertz regime is dominated
by the slower chain modes [26,43,44].
Fig. 8 also presents the T13 dispersion for the hybrids.
The effect of the nanoparticles’ introduction in the PCL
matrix is more pronounced in the dynamics of the ﬂexible-
amorphous part, in particular for the PCL/SiO2 system. The
T13 in this system shows a decrease with frequency in the
range 1 to 9 MHz. This might be related to the small
diameter of SiO2, around 12 nm (in comparison with the
other two systems), which helps to achieve a more uniform
distribution in the PCL ﬂexible-amorphous regions and
promotes an increase of disorder in these regions [45].
The proton spin-lattice NMR measurements for PCL
with different amounts of nevirapine are shown in Fig. 9.
The magnetization decay for the all PCL/nevirapine hybrids
is also described by a triexponential behavior, characterized
by three T1 values. This magnetization behavior can be
observed for PCL/nevirapine at 5% w/w, 10% w/w and 20%Fig. 9. Comparison of the frequency dependence of the proton spin-lattice
relaxation time for the PCL/nevirapine hybrids.w/w in the frequencies up to 1 MHz, 800 KHz and
1 MHz, respectively. As mentioned before, short values of
T1 (<2–3 ms) could not be reliably measured with our
FFC equipment for all systems except PCL/nevirapine with
10% w/w.
The PCL/nevirapine hybrids showed some changes in
the T11, T12 and T13 values, indicating that the nevirapine
was distributed in the crystalline as well as in the amor-
phous parts of the PCL (see Fig. 9). However, the most
pronounced change occurred in T13, which corresponds to
the ﬂexible-amorphous phase.
The comparison of T13 for PCL/nevirapine at 5%w/w,10%
w/w and 20% w/w concentrations shows a diminishing
effect of the nevirapine on PCL dynamics for larger con-
centrations (see Fig. 9). In fact, the introduction of a small
amount of nevirapine, such as 5% w/w, produces a more
pronounced change in the PCL matrix dynamics in ﬂexible-
amorphous regions, by reducing the T13 and saturates for
slightly larger concentrations The increase of drug con-
centration above 5% w/w seems to have the opposite effect
on the PCL dynamics, slowing the polymer tail end chain
movements, as can be seen from the increased T13 values at
lower frequencies (in the kilohertz range), which is domi-
nated by the slower chain mode [44,46].
Figs. 10–12 show the spin-lattice relaxation time
dispersion proﬁles in the frequency range 10 kHz to
300 MHz, for PCL/S7/nevirapine, PCL/TiO2/nevirapine and
PCL/SiO2/nevirapine hybrids with different concentrations
of nevirapine. The magnetization decay presented by all
PCL/nanoparticles/nevirapine hybrids are similar to the one
found for the PCL/nanoparticles systems.
Figs. 10–12 show that even a small amount of nevira-
pine, such as 5% w/w, in the PCL/nanoparticle systems was
able to cause some changes in the molecular dynamics of
the PCL chains, especially in the ﬂexible-amorphous zones,
making the polymer chains’ movements faster and
reducing T13. However, the increase of the polymer chain
mobility tends to disappear with increasing concentration
of nevirapine. Also, the presence of nevirapine and nano-
particles at the same time in the rigid-amorphous and
ﬂexible-amorphous zones decreased the polymer chainFig. 10. Comparison of the frequency dependence of the proton spin-lattice
relaxation time for the PCL/S7/nevirapine hybrids.
Fig. 11. Comparison of the frequency dependence of the proton spin-lattice
relaxation time for the PCL/TiO2/nevirapine hybrids.
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PCL/nanoparticle/nevirapine systems were mutually
similar but very different from the PCL systems without
nanoparticles but with 5% w/w nevirapine (Fig. 9). There
was no signiﬁcant difference in the proton spin-lattice
relaxation time, T11, of the systems with nanoparticles
and 10% w/w nevirapine (Figs. 10–12).
The 20% w/w PCL/nevirapine system (Fig. 9) presented a
shorter proton spin-lattice relaxation time, T11, compared
to the other systems with 20% w/w PCL/nanoparticles/ne-
virapine (Figs.10–12). Besides that, the T11 values were very
similar among the systems with nanoparticles and 20% w/
w nevirapine. The T13 values were also similar among the
systems with PCL/nanoparticles/20% w/w nevirapine and
neat PCL, indicating similar behavior and the same molec-
ular mobility as the neat PCL.
In Fig. 10, the PCL/S7/nevirapine system presented
higher T11 compared to the systems with neat PCL (Fig. 9).
This can be explained by the fact that the clay can restrict
the molecular movements in the crystalline part of the
PCL chains, hindering the polymer’s inter segmental in-
teractions, causing a geometrical constraint and increasingFig. 12. Comparison of the frequency dependence of the proton spin-lattice
relaxation time for the PCL/SiO2/nevirapine hybrids.T11 [47]. When nevirapine is added, the clay’s effect is
reversed and the T11 decreases. This compensatory mech-
anism is clearly seen in the values of T11 for the PCL/S7/5%
w/w nevirapine system, comparing Figs. 9 and 10, since in
Fig. 9 the T11 increased with the presence of S7 and in
Fig. 10 the T11 decreased with the introduction of 5% w/w
nevirapine. So, the presence of nevirapine molecules can
modify the polymer arrangement around the S7 clay [48].
Also, there was no signiﬁcant difference in the T13 for this
system.
Fig. 11 shows that the 5% w/w PCL/SiO2/nevirapine
system presents a higher T11 in comparison with the other
hybrids. However, the incorporation of SiO2 nanoparticles
did not signiﬁcantly affect themolecular motions of the PCL
chains (see Fig. 8). Nevertheless, the incorporation of ne-
virapine and SiO2 together changed the T11 values, sug-
gesting some adjustment in the molecular dynamics in the
PCL crystalline part. The T11 dispersion presented by the
PCL/SiO2/nevirapine systems with 5% w/w and 10% w/w is
different, indicating that the drug was also dispersed in the
crystalline region, turning this area more rigid with less
mobility [23].
The effect of SiO2 nanoparticles is more pronounced in
the ﬂexible-amorphous area, increasing the chains’
mobility, as can be seen in the T13 proﬁle in Fig. 8. However,
the further addition of nevirapine and its dispersion in the
amorphous regions affects the PCL dynamics by reducing
the polymer chains’mobility in these regions, in contrast to
the effect produced by the presence of the SiO2 nano-
particles. This fact may be related to the small diameter of
the silica nanoparticles (in the range of 12 nm) [45].
Fig. 12 shows the spin-lattice relaxation dispersion in
the Larmor frequency range of 10 kHz to 300 MHz for the
PCL/TiO2/nevirapine samples. These systems did not show
any changes in T11 and T13. The introduction of the nano-
particles and nevirapine seem to have a compensatory ef-
fect on mobility of the polymer chains in the amorphous
regions of these systems. The simultaneous presence of
nanoparticles and nevirapine should have increased the
disorder in the amorphous area, but the opposite effect
happened and the disorder of this systemwas reduced [46].
3.3. Effect of temperature on the spin-lattice relaxation time
To study the molecular dynamics at human body tem-
perature, the spin-lattice relaxation time measurements
were performed as a function of Larmor frequency at 37 C
for some selected samples. For each sample, the measure-
ments were performed ﬁrst at 23 C and then at 37 C.
The results obtained are shown in Figs. 13–16 for the
PCL, PCL/S7, PCL/SiO2, PCL/TiO2, 10% w/w PCL/nevirapine,
10% w/w PCL/S7/nevirapine, 10% w/w PCL/SiO2/nevirapine
and 10% w/w PCL/TiO2/nevirapine hybrids, respectively.
The magnetization decay presented the same triexponen-
tial behavior detected for the systems at room temperature.
Figs. 13 and 14 present the spin-lattice relaxation
dispersion in the Larmor frequency for PCL and PCL hybrids.
It can be seen that all spin-lattice relaxation times (T11, T12
and T13) increased at 37 C. Hence, the T11 and T12 values for
all the samples were higher compared with the corre-
sponding values obtained at room temperature, indicating
Fig. 13. (a) Experimental T1 dispersion results for T ¼ 25 C and T ¼ 37 C for neat PCL. (b) Experimental T1 dispersion results for T ¼ 25 C and T ¼ 37 C for PCL/
S7 hybrids.
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the samples at 37 C are higher and have a distinct proﬁle
(ﬂatter) compared to their counterparts at 23 C, especially
for frequencies below 9 MHz.
This behavior might be unexpected in view of the
Arrhenius temperature dependence characteristic of ther-
mally activated processes. Indeed, upon approaching the
polymer melting temperature, the molecular mobility is
expected to increase in the ﬂexible-amorphous regions, the
rigid-amorphous interface and in the crystalline phase
(a-relaxation), thus leading to a decrease of the spin-lattice
relaxation time with increasing temperature [7,42,49].
The observed behavior might be related to an annealing
effect due to the temperature increase (Figs. 13 and 14),
favoring some molecular rearrangement and leading to an
increase in molecular order and an increase of the proton
spin-lattice relaxation times for all systems and phase re-
gions. The relatively low melting temperature of these
systems (w50 C) might favor this annealing-type process,
but the fact that the samples where heated not too close to
themelting point seems tomake it reversible. Additional T1
measurements performed after cooling the systems back to
room temperature (w23 C), where statistically equal to
those initially obtained [49].
In this annealing-type process, the molecular reorgani-
zation of small crystallites and amorphous regions intoFig. 14. (a) Experimental T1 dispersion results for T ¼ 25 C and T ¼ 37 C for PCL/Si
for PCL/TiO2 hybrids.spherulites is in a way similar to the classic annealing-type
process observed for most semi crystalline polymers
[50,51].
The slight increase of T11 at 37 C (Figs. 13 and 14), for all
the samples, is probably caused by chain rearrangement
leading to more ordered crystalline structures with less
molecular mobility in the crystalline regions. The T12 and
T13 relaxation times for the rigid-amorphous and ﬂexible-
amorphous phase also increased, possibly due to the
additional constraints imposed on the amorphous phase
due to the increased amount of crystalline phase.
We suggest that this annealing-type process is accom-
panied by structural reorganization at the interfaces be-
tween the crystalline and amorphous regions, and this
reorganization is strongly inﬂuenced by the chain dy-
namics in the crystalline and amorphous phases. The
annealing-type process leads to an increase of crystalline
order (presumably more pronounced close to the layer
surface), and a continuous shift of the interface towards the
inner part of the amorphous regions, reducing the thick-
ness of the ﬂexible-amorphous regions [50–52].
Figs. 15 and 16 present the three spin-lattice relaxation
times as a function of the Larmor frequency for PCL/nano-
ﬁllers/nevirapine hybrids.
It can be seen that all spin-lattice relaxation times
(T11, T12 and T13) increased at 37 C. Thus, the T11 and T12O2 hybrids. (b) Experimental T1 dispersion results for T ¼ 25 C and T ¼ 37 C
Fig. 15. (a) Experimental T1 dispersion results for T¼ 25 C and T ¼ 37 C for 10% w/w PCL/nevirapine hybrids. (b) Experimental T1 dispersion results for T ¼ 25 C
and T ¼ 37 C for 10% w/w PCL/S7/nevirapine hybrids.
M.S.S.B. Monteiro et al. / Polymer Testing 32 (2013) 553–566 561values for all the samples are larger than those obtained at
23 C. As observed previously for the temperature effect on
the PC/nanoparticles systems, the T13 values also present
distinct proﬁles (ﬂatter) at 37 C when compared to their
counterparts at 23 C, especially for frequencies below
9 MHz.
In view of the experimental frequency dependence ob-
tained for the proton spin-lattice relaxation times, T12 and
T13, these T1 dispersions were analyzed with a power law of
the type T1wn
p
L , where the exponent p can change from
one frequency range to another. This T1 frequency depen-
dence was obtained within the frame of the renormalized
Rouse model for polymer melts. The renormalized Rouse
model is used to explain the molecular dynamics of bulk
polymers with molecular weight above the critical mass
(Mw > Mc) and is expressed by different power laws cor-
responding to different motion regimes, such as high and
lowmode and inter-segment dipolar interaction limits. The
modiﬁed Rouse model takes into account the memory
function, representing all chain interactions [53,54].
Only the spin-lattice relaxation times T12 and T13 were
ﬁtted using themodiﬁed Rousemodel, since these times are
related to the polymer’s amorphous part, presenting higher
mobility and fastermotions. However, it was not possible to
use this model to analyze the T11 value, since this spin-
lattice relaxation time is related to the crystalline part.Fig. 16. (a) Experimental T1 dispersion results for T ¼ 25 C and T ¼ 37 C for 10%
T ¼ 25 C and T ¼ 37 C for 10% w/w PCL/TiO2/nevirapine hybrids.The resulting power law exponents for each sample are
presented in Figs. 17–22 together with the experimental
results and curves ﬁtted. They are similar to those obtained
for the modiﬁed power law regime for the spin-lattice
relaxation dispersion for ﬂexible polymer melts without
mesogenic groups, which form ordered mesophases in the
temperature intervals between the solid and the isotropic
melt phases [23,54].
The results obtained here demonstrate the sensitivity of
NMR relaxometry to microstructural changes.
The spin-lattice relaxation times of the samples ﬁtted
using the modiﬁed Rouse power function presented T12
exponent values around 0.73 (Figs. 17–22). The highest
frequency regime is similar to the one reported for region I
of the mesophase of polymer melts, which is usually
described by the power law T1 w n0.73  0.05 [43,54]. This
suggests that the “rigid amorphous” phase of the systems
studied in this work, assigned to T12, present similar mo-
lecular dynamics behavior to that found in region I of the
mesophase of the melted polymers [23]. In region I of the
mesophase, for polymer melts in the normalized Rouse
model, the polymers present some order and there are
some intra-segment spin interactions between the polymer
chains [21,26]. This means these regions in the polymer
samples developed are amorphous but have some degree
of order and some constraints in molecular movement.w/w PCL/SiO2/nevirapine hybrids. (b) Experimental T1 dispersion results for
Fig. 17. Spin-lattice relaxation time as a function of the Larmor frequency (n) for: (a) PCL, (b) PCL/S7 hybrids, (c) PCL/SiO2 hybrids and (d) PCL/TiO2 hybrids. The
blue and black lines are best ﬁts of the renormalized Rouse model. The ﬁtting parameters of the power law dependence of T1 as a function of the Larmor
frequency are shown in the graphs. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 18. Spin-lattice relaxation time as a function of the Larmor frequency (n) for: (a) 5% w/w PCL Nev hybrids, (b) 5% w/w PCL/S7 Nev hybrids, (c) 5% w/w PCL/
SiO2 Nev hybrids and (d) 5% w/w PCL/TiO2 Nev hybrids. The blue and black lines are the best ﬁts of the renormalized Rouse model. The ﬁtting parameters of the
power law dependence of T1 as a function of the Larmor frequency are shown in the graphs. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
M.S.S.B. Monteiro et al. / Polymer Testing 32 (2013) 553–566562
Fig. 19. Spin-lattice relaxation time as a function of the Larmor frequency (n) for: (a) 10% w/w PCL Nev hybrids, (b) 10% w/w PCL/S7 Nev hybrids, (c) 10% w/w PCL/
SiO2 Nev hybrids and (d) 10% w/w PCL/TiO2 Nev hybrids. The blue and black lines are the best ﬁts of the renormalized Rouse model. The ﬁtting parameters of the
power law dependence of T1 as a function of the Larmor frequency are shown in the graphs. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
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around 0.5 and 0.25 in the frequency range from 10 kHz to
9 MHz (Figs. 17–22). These values suggest that the ﬂexible-
amorphous regions of the samples possess similar molec-
ular dynamics to those reported for region I and region II of
the isotropic phase of melted polymers reported in [43,54].
This polymer amorphous phase seems to be more disor-
ganized, with higher molecular mobility, as in the isotropic
phase in the melted polymers. In melted polymers, region I
is dominated by intra-segment spin interactions with faster
movements and region II is dominated by intra-segment
spin interactions with slower movements [21,26,54].
Therefore, the fast relaxation mode detected for the
ﬂexible-amorphous regions of the studied PCL systems
might also be related to higher mobility of “tail segments”,
and the slow relaxation mode might be related to the de-
gree of molecular conﬁnement in those regions.
Besides this, the high frequency regime for T13, above
10 MHz, is described by a small inclination with the power
law exponent around T1w n0.10 (Figs. 17–22). This result is
attributed to local ﬂuctuations within the Kuhn segments,
as was previously observed in PEO and PIP melts [55].
When a small amount of a small molecule is introduced
in a hybrid system (drug molecules or nanoparticles), the
isotropic behavior of the amorphous part increases, raising
the mobility/ﬂexibility of the polymer chain and reducing
the T13. In fact, with the introduction of larger nano-
particles, such as clay, or a higher amount of the drug, orwhen nanoparticles and drug molecules are introduced at
the same time, a decrease in mobility can be expected [54].
The incorporation of titanium nanoparticles in the PCL
matrix did not change the order of region I of the isotropic
phase, as reported for polymer melts in the normalized
Rousemodel, and the drug introduction did not change this
behavior.
In the hybrids containing nevirapine (Figs. 18–20), the
drugseems tobedispersedmainly in theﬂexible-amorphous
zone,which is attributed to theT13 andhelped tokeep theT13
constant at high frequencies. The drug introduction changed
the polymer molecular dynamics of region I to region II, re-
ported for polymer melts in the modiﬁed Rouse model.
However, the polymer tails were not affected, since the T13
values were similar to those of the hybrids without the drug
at high frequency. This means that the drug caused slower
movements in the amorphous part [46].
In the systems containing clay, the molecular dynamics
changed in the amorphous part. However, when the drug
was added together with the clay, the molecular motions in
the ﬂexible-amorphous part became more constrained.
In the case of the systems containing silica nano-
particles, which are smaller and consequently more
dispersed than clay nanoparticles, faster molecular move-
ments were detected in the ﬂexible-amorphous regions.
However, the incorporation of silica nanoparticles and the
nevirapine molecules together in the hybrid system
increased the order in the ﬂexible-amorphous regions.
Fig. 20. Spin-lattice relaxation time as a function of the Larmor frequency (n) for: (a) 20% w/w PCL Nev hybrids, (b) 20% w/w PCL/S7 Nev hybrids, (c) 20% w/w PCL/
SiO2 Nev hybrids and (d) 20% w/w PCL/TiO2 Nev hybrids. The blue and black lines are the best ﬁts of the renormalized Rouse model. The ﬁtting parameters of the
power law dependence of T1 as a function of the Larmor frequency are shown in the graphs. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.)
Fig. 21. Spin-lattice relaxation time as a function of the Larmor frequency (n) for T ¼ 37 C for: (a) PCL hybrids, (b) PCL/S7 hybrids, (c) PCL/SiO2 hybrids and (d)
PCL/TiO2 hybrids. The blue and black lines are the best ﬁts of the renormalized Rouse model. The ﬁtting parameters of the power law dependence of T1 as a
function of the Larmor frequency are shown in the graphs. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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Fig. 22. Spin-lattice relaxation time as a function of the Larmor frequency (n) for T ¼ 37 C for: (a) 10% w/w PCL Nev hybrids, (b) 10% w/w PCL/S7 Nev hybrids, (c)
10% w/w PCL/SiO2 Nev hybrids and (d) 10% w/w PCL/TiO2 Nev hybrids. The blue and black lines are the best ﬁts of the renormalized Rouse model. The ﬁtting
parameters of the power law dependence of T1 as a function of the Larmor frequency are shown in the graphs. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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PCL hybrids containing nevirapine and different nano-
particles were prepared using the solvent casting technique
to produce polymer ﬁlms. Their structures were charac-
terized by XRD and 1H NMR relaxometry. The XRD showed
the PCL crystallization is hindered with a higher amount of
nevirapine, lowering the PCL crystalline degree and
changing the PCL semi-crystalline structure to a less or-
dered structure and the nevirapine has amorphous distri-
bution inside the PCL matrix. The NMR study enabled
distinguishing the different polymer regions and provided
information about the molecular dynamics under
conﬁnement conditions, namely, that the hybrids have
three distinct environments: (i) rigid crystallites, which are
more organized with slower and more restricted chain
motions, presenting higher T1 values (T11); (ii) a “rigid-
amorphous” region, where the PCL chains have interme-
diate mobility, presenting intermediate T1 values (T12), and
where the polymer chains are stuck in the crystalline parts;
and (iii) a ﬂexible- amorphous region, where the PCL chains
are more mobile and move faster, thus presenting shorter
intrinsic T1 values (T13). The proton spin-lattice relaxom-
etry showed that the PCL chains have more restricted
motions in the presence of S7 clay and that the clay layers
were able to increase the system’s arrangement and inﬂu-
ence the development of crystallites. The nanoparticles
TiO2 and SiO2 had less inﬂuence on the polymer dynamics.
The hybrid systems, such as the PCL/nevirapine hybrids,showed major changes in the T13 values, indicating that the
nevirapine molecules were better distributed in the
ﬂexible-amorphous part of the PCL. Nevertheless, increased
drug concentration restricted and slowed the polymer tail
end chain movements. In the PCL/S7 system, the clay
restricted the molecular movements in the crystalline part
of the PCL chains, hindering the polymer inter-segmental
interactions. However, when nevirapine was added (PCL/
S7/Nevirapine), the clay’s effect was reversed. Thus, the
nevirapinemolecules canmodify the polymer arrangement
around the S7 clay. The incorporation of SiO2 nanoparticles
did not signiﬁcantly affect themolecular motions of the PCL
chains, but the SiO2 nanoparticles had a more pronounced
effect in the amorphous area. The PCL/TiO2/nevirapine did
not show any changes. The concomitant introduction of the
nanoparticles and nevirapine promoted a compensatory
effect in the polymeric system, since the presence of both
compounds reduced the mobility in the amorphous part
acquired when only the drug was introduced.
When the temperature was increased to 37 C, an in-
crease of the proton spin-lattice relaxation times T11, T12,
and T13 was observed, indicating that the systems are more
ordered at 37 C. We believe this result is due to an
annealing-type process, in which reorganization of small
crystallites into spherulites might occur. Finally, from our
results we conclude that the strength of the interaction
between PCL/nanoparticle hybrid and drug depends on the
nanoparticle type (clay, SiO2 or TiO2), which can have a
direct inﬂuence on the drug release.
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